Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2005
09/01/2005US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto
09/01/2005US20050192279 Pyridazinones as antagonists of alpha4 integrins
09/01/2005US20050192277 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders
09/01/2005CA2557433A1 Quinazoline derivatives and therapeutic use thereof
09/01/2005CA2556268A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2555970A1 Therapeutic amide derivatives
09/01/2005CA2555402A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005CA2555073A1 Amino heterocyclic modulators of chemokine receptor activity
09/01/2005CA2554774A1 Novel heterocyclic compound
09/01/2005CA2554686A1 Compounds
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1568693A1 Process for producing quinolinecarbaldehyde
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1567518A2 Oxime ester photoinitiators with heteroaromatic groups
08/31/2005EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
08/31/2005EP1567506A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
08/31/2005EP1567504A1 Antibacterial agents
08/31/2005EP1567502A1 Substituted dihydrophenanthridinesul fonamides
08/31/2005EP1567496A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
08/31/2005EP1567493A1 Phenyl substituted piperidine compounds for use as ppar activators
08/31/2005EP1567489A1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa
08/31/2005EP1567488A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
08/31/2005EP1567151A1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer
08/31/2005EP1395576B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1237875B1 Substituted imidazole neuropeptide y y5 receptor antagonists
08/31/2005EP1182200B1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005CN1662527A Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
08/31/2005CN1662525A Preparation for the production of 1, 2, 4-triazolymethyl-oxiranes
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662519A Heterocyclic compounds as glycine transport inhibitors
08/31/2005CN1662518A Processes for producing epoxytriazole derivative and intermediate therefor
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662498A Novel tetrahydropyridine derivatives as renin inhibitors
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1660841A Itraconazole hydrochloride, oral solid combination and preparation method
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660821A Oxodiethylenediamine derivative and light stabilized composition
08/31/2005CN1660818A Process for the manufacture of organic compounds
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660811A Compound of 1, 4-substituted benzenes and preparing method and application
08/30/2005US6936720 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936626 Retinoic acid mimetic anilides
08/30/2005US6936616 Pyrimidine matrix metalloproteinase inhibitors
08/30/2005US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation
08/30/2005US6936610 Heterocyclic derivatives
08/30/2005US6936602 Benzazepine derivatives, process for the preparation of the same and uses thereof
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/30/2005US6936325 Optical recording medium
08/30/2005CA2133152C Piperidines and piperazines with affinity for 5-ht receptors
08/25/2005WO2005077944A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005WO2005077943A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
08/25/2005WO2005077942A1 Process for preparing substituted benzopyran compounds
08/25/2005WO2005077940A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
08/25/2005WO2005077937A1 Substituted hydroxamic acid derivatives as tnf inhibitors
08/25/2005WO2005077932A2 Chemokine receptor antagonists
08/25/2005WO2005077922A2 Process for the preparation of substituted triazole compounds
08/25/2005WO2005077918A1 Pth agonists
08/25/2005WO2005077915A1 Pyridazinones as antagonists of a4 integrins
08/25/2005WO2005077914A1 PYRIDAZINONE UREAS AS ANTAGONISTS OF α4 INTEGRINS
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077896A1 Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
08/25/2005WO2005077463A2 Ligand for a monoamine receptor or transporter for treating addiction or dependence
08/25/2005WO2005077361A1 Novel, sustained-action beta-2-agonists and their use as medicaments
08/25/2005WO2005077344A2 Hydantoin derivatives as inhibitors of cellular necrosis
08/25/2005US20050187390 Bicyclic heteroaryl derivatives
08/25/2005US20050187387 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187284 Integrin receptor inhibitors
08/25/2005US20050187279 Indazole derivatives useful for the treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizure etc.
08/25/2005US20050187275 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide
08/25/2005US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
08/25/2005US20050187270 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/25/2005US20050187266 2-Methyl-2-{3-[({[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]carbonyl}amino)methyl]phenoxy}propanoic acid; polycystic ovarian syndrome; polycystic obesity; dietetics; hypoglycemic agents; antilipemic and - cholesterol agents; hypertriglyceridemia; insulin resistance; metabolic disorders; PPAR modulators
08/25/2005US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050187257 Methods of treating sepsis
08/25/2005US20050187238 Benzofuran derivatives, their production and use
08/25/2005US20050187236 Nitrogen-containing aromatic derivatives
08/25/2005US20050187231 4-aminoquinazolines e.g. 4-(4-phenylbutylamino)quinazoline; antiproliferative agents; antitumor agents; hyperproliferative disorders, including tumors, such as breast, brain, and kidney tumors
08/25/2005US20050187222 Therapy for impotency, erectile dysfuction; benign prostatic hyperplasia; hypotensive agents; congestive heart failure; vision defects; neurodegenerative disorders; incotinence; cognition activators
08/25/2005US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines
08/25/2005US20050186630 Extended tethering approach for rapid identification of ligands
08/25/2005CA2556398A1 Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
08/25/2005CA2555825A1 Process for the preparation of substituted triazole compounds
08/25/2005CA2555817A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
08/25/2005CA2555685A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005CA2555594A1 Pyridazinones as antagonists of a4 integrins
08/25/2005CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins
08/25/2005CA2554378A1 Bicycloamide derivative
08/25/2005CA2553630A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
08/25/2005CA2552871A1 Novel, sustained-action beta-2-agonists and their use as medicaments
08/25/2005CA2536622A1 Inhibitors of cellular necrosis
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 694